QQQ   354.12 (+0.27%)
AAPL   181.33 (+0.42%)
MSFT   326.42 (+0.36%)
META   264.06 (-0.20%)
GOOGL   122.18 (+0.03%)
AMZN   123.46 (-0.64%)
TSLA   244.66 (+4.17%)
NVDA   387.25 (+0.56%)
NIO   7.86 (+0.90%)
BABA   85.85 (-0.34%)
AMD   123.97 (+2.41%)
T   16.02 (-0.31%)
F   13.82 (+1.77%)
MU   64.84 (-0.73%)
CGC   0.67 (-3.08%)
GE   105.27 (-0.75%)
DIS   91.87 (-0.71%)
AMC   4.75 (+1.50%)
PFE   38.97 (-0.31%)
PYPL   63.21 (-1.60%)
NFLX   423.65 (+3.49%)
QQQ   354.12 (+0.27%)
AAPL   181.33 (+0.42%)
MSFT   326.42 (+0.36%)
META   264.06 (-0.20%)
GOOGL   122.18 (+0.03%)
AMZN   123.46 (-0.64%)
TSLA   244.66 (+4.17%)
NVDA   387.25 (+0.56%)
NIO   7.86 (+0.90%)
BABA   85.85 (-0.34%)
AMD   123.97 (+2.41%)
T   16.02 (-0.31%)
F   13.82 (+1.77%)
MU   64.84 (-0.73%)
CGC   0.67 (-3.08%)
GE   105.27 (-0.75%)
DIS   91.87 (-0.71%)
AMC   4.75 (+1.50%)
PFE   38.97 (-0.31%)
PYPL   63.21 (-1.60%)
NFLX   423.65 (+3.49%)
QQQ   354.12 (+0.27%)
AAPL   181.33 (+0.42%)
MSFT   326.42 (+0.36%)
META   264.06 (-0.20%)
GOOGL   122.18 (+0.03%)
AMZN   123.46 (-0.64%)
TSLA   244.66 (+4.17%)
NVDA   387.25 (+0.56%)
NIO   7.86 (+0.90%)
BABA   85.85 (-0.34%)
AMD   123.97 (+2.41%)
T   16.02 (-0.31%)
F   13.82 (+1.77%)
MU   64.84 (-0.73%)
CGC   0.67 (-3.08%)
GE   105.27 (-0.75%)
DIS   91.87 (-0.71%)
AMC   4.75 (+1.50%)
PFE   38.97 (-0.31%)
PYPL   63.21 (-1.60%)
NFLX   423.65 (+3.49%)
QQQ   354.12 (+0.27%)
AAPL   181.33 (+0.42%)
MSFT   326.42 (+0.36%)
META   264.06 (-0.20%)
GOOGL   122.18 (+0.03%)
AMZN   123.46 (-0.64%)
TSLA   244.66 (+4.17%)
NVDA   387.25 (+0.56%)
NIO   7.86 (+0.90%)
BABA   85.85 (-0.34%)
AMD   123.97 (+2.41%)
T   16.02 (-0.31%)
F   13.82 (+1.77%)
MU   64.84 (-0.73%)
CGC   0.67 (-3.08%)
GE   105.27 (-0.75%)
DIS   91.87 (-0.71%)
AMC   4.75 (+1.50%)
PFE   38.97 (-0.31%)
PYPL   63.21 (-1.60%)
NFLX   423.65 (+3.49%)
NASDAQ:EDAP

Edap Tms (EDAP) Competitors

$8.98
-0.05 (-0.55%)
(As of 12:50 PM ET)
Compare
Today's Range
$8.50
▼
$9.19
50-Day Range
$9.03
▼
$11.92
52-Week Range
$6.02
▼
$12.65
Volume
78,692 shs
Average Volume
63,060 shs
Market Capitalization
$331.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

EDAP vs. ZYXI, AXGN, HYPR, VRAY, FONR, BLFS, OM, RCEL, VNDA, and VOR

Should you be buying Edap Tms stock or one of its competitors? The main competitors of Edap Tms include Zynex (ZYXI), AxoGen (AXGN), Hyperfine (HYPR), ViewRay (VRAY), FONAR (FONR), BioLife Solutions (BLFS), Outset Medical (OM), AVITA Medical (RCEL), Vanda Pharmaceuticals (VNDA), and Vor Biopharma (VOR). These companies are all part of the "medical" sector.

Edap Tms vs.

Edap Tms (NASDAQ:EDAP) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability.

Edap Tms has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500.

Edap Tms currently has a consensus price target of $13.75, suggesting a potential upside of 52.78%. Zynex has a consensus price target of $19.63, suggesting a potential upside of 125.57%. Given Zynex's higher probable upside, analysts plainly believe Zynex is more favorable than Edap Tms.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edap Tms
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Zynex
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Edap Tms' average media sentiment score of 0.00 equaled Zynex's average media sentiment score.

Company Overall Sentiment
Edap Tms Neutral
Zynex Neutral

Zynex has higher revenue and earnings than Edap Tms. Edap Tms is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edap Tms$57.97 million5.73-$3.09 million-$0.30-30.00
Zynex$158.17 million2.02$17.05 million$0.4519.33

48.8% of Edap Tms shares are owned by institutional investors. Comparatively, 28.6% of Zynex shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 46.6% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Zynex has a net margin of 10.19% compared to Edap Tms' net margin of -19.22%. Zynex's return on equity of 26.02% beat Edap Tms' return on equity.

Company Net Margins Return on Equity Return on Assets
Edap Tms -19.22% -16.56% -11.31%
Zynex 10.19% 26.02% 14.91%

Edap Tms received 323 more outperform votes than Zynex when rated by MarketBeat users. Likewise, 63.50% of users gave Edap Tms an outperform vote while only 46.15% of users gave Zynex an outperform vote.

CompanyUnderperformOutperform
Edap TmsOutperform Votes
341
63.50%
Underperform Votes
196
36.50%
ZynexOutperform Votes
18
46.15%
Underperform Votes
21
53.85%

Summary

Zynex beats Edap Tms on 10 of the 15 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EDAP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EDAP vs. The Competition

Export to Excel
MetricEdap TmsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$332.19M$3.43B$4.58B$6.30B
Dividend YieldN/A1.57%2.37%6.18%
P/E Ratio-30.007.3996.0512.11
Price / Sales5.7354.523,433.3788.73
Price / CashN/A15.2991.54113.43
Price / Book4.416.104.705.32
Net Income-$3.09M$86.83M$117.88M$192.87M
7 Day Performance-9.64%0.72%1.24%1.93%
1 Month Performance-20.07%-0.69%1.80%5.56%
1 Year Performance28.57%20.26%9.15%3.45%

Edap Tms Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZYXI
Zynex
2.0463 of 5 stars		$9.18
-1.4%		$19.63
+113.8%		+17.2%$336.45M$158.17M20.40774
AXGN
AxoGen
2.1102 of 5 stars		$8.97
+2.9%		$17.00
+89.5%		-1.1%$383.92M$138.58M-15.47428
HYPR
Hyperfine
2.0983 of 5 stars		$1.89
+8.0%		$2.45
+29.6%		-23.0%$134.34M$6.81M-2.15186News Coverage
VRAY
ViewRay
2.4268 of 5 stars		$0.62
-1.6%		$3.18
+413.9%		-80.6%$113.43M$102.21M-1.03267
FONR
FONAR
0 of 5 stars		$17.03
-1.5%		N/A+10.4%$113.04M$97.68M0.00495Positive News
BLFS
BioLife Solutions
1.7162 of 5 stars		$24.08
+1.7%		$28.00
+16.3%		+60.3%$1.05B$161.76M-7.06432
OM
Outset Medical
0.9327 of 5 stars		$22.93
+6.1%		$24.50
+6.8%		+4.5%$1.13B$115.38M-6.50444
RCEL
AVITA Medical
1.8807 of 5 stars		$14.17
+2.0%		$18.75
+32.3%		+182.4%$358.93M$34.42M-13.50116Positive News
VNDA
Vanda Pharmaceuticals
1.7955 of 5 stars		$6.25
+2.5%		N/A-36.9%$359.03M$256.69M21.55278Analyst Upgrade
VOR
Vor Biopharma
1.9306 of 5 stars		$5.33
+7.0%		$16.19
+203.7%		+0.8%$356.90MN/A-2.46135Gap Up

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:EDAP) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -